Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01469767 · ClinicalTrials.gov registry record · Phase 2
Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis
A Phase 2 study, sponsored by Wake Forest University.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT01469767 is a Phase 2 study that has completed, run by Wake Forest University. The registered enrollment target is 10 participants.
The verdict
NCT01469767, a Phase 2 study, has completed, sponsored by Wake Forest University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the efficacy of short-term treatment with fluocinonide cream 0.1% (Vanos®) in the treatment of atopic dermatitis (AD).
Interventions
- DRUG Fluocinonide cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-02-01 |
| Est. Completion | 2013-08-17 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01469767
The ClinicalTrials.gov registry entry for NCT01469767 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University, which has 100 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluocinonide cream is the first listed.
NCT01469767 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01469767 about?
NCT01469767 is a clinical study titled "Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis". The purpose of this study is to assess the efficacy of short-term treatment with fluocinonide cream 0.1% (Vanos®) in the treatment of atopic dermatitis (AD).
What is the current status of trial NCT01469767?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2012-02-01. Estimated completion is 2013-08-17.
What interventions are being tested in trial NCT01469767?
The interventions under investigation include: Fluocinonide cream (DRUG).
Who is sponsoring clinical trial NCT01469767?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.